These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 2154925)
1. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329 [TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807 [TBL] [Abstract][Full Text] [Related]
7. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964 [TBL] [Abstract][Full Text] [Related]
8. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group. Rennels MB; Wasserman SS; Glass RI; Keane VA Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626 [TBL] [Abstract][Full Text] [Related]
10. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants. Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513 [TBL] [Abstract][Full Text] [Related]
11. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Joensuu J; Koskenniemi E; Pang XL; Vesikari T Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561 [TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological studies of rotavirus vaccines. Vesikari T Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):437-47. PubMed ID: 2851185 [TBL] [Abstract][Full Text] [Related]
13. Live attenuated human rotavirus vaccine, Rotarix. Bernstein DI Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369 [TBL] [Abstract][Full Text] [Related]
14. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534 [TBL] [Abstract][Full Text] [Related]
15. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. Bhandari N; Sharma P; Taneja S; Kumar T; Rongsen-Chandola T; Appaiahgari MB; Mishra A; Singh S; Vrati S; J Infect Dis; 2009 Aug; 200(3):421-9. PubMed ID: 19545211 [TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. Clark HF; Bernstein DI; Dennehy PH; Offit P; Pichichero M; Treanor J; Ward RL; Krah DL; Shaw A; Dallas MJ; Laura D; Eiden JJ; Ivanoff N; Kaplan KM; Heaton P J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258 [TBL] [Abstract][Full Text] [Related]